Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Soligenix
SoligenixPRINCETON, NJ
2 programs
2
HypericinPhase 21 trial
HypericinPhase 21 trial
Active Trials
NCT05380635Completed9Est. Aug 2022
NCT06149247Completed10Est. Jun 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
SoligenixHypericin
SoligenixHypericin

Clinical Trials (2)

Total enrollment: 19 patients across 2 trials

NCT06149247SoligenixHypericin

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Start: Dec 2023Est. completion: Jun 202410 patients
Phase 2Completed
NCT05380635SoligenixHypericin

PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma

Start: May 2022Est. completion: Aug 20229 patients
Phase 2Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
10m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
10m ago

Office Administrator

SystImmune
10m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
20m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
24m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
24m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)